Top 10 Premier Cancer Treatment Hospitals in Asia

1. ASAN Medical Center (AMC)

ASAN is the leading central tertiary hospital in Seoul, comprising a network of 7 secondary hospitals in various localities throughout South Korea. The ASAN Medical Center alone is a collection of large, high-quality specialty institutes with a total of 2,700 beds, 67 operating rooms, 1,700 physicians and surgeons, 3,600 nurses, 24 centers, and 42 treatment specialties. These institutes are uniformly excellent in technology, expertise, and collaboration to deliver the best results for patients. As a result, ASAN consistently ranks among the world's top hospitals for diseases such as cancer, liver transplantation, organ transplantation, pediatrics, ophthalmology, and more.

The hospital not only caters to the general public but also focuses on high-end health check-up packages for affluent clients such as businesspeople, chairmen, or conglomerates. Therefore, ASAN has not only achieved the number 1 brand index in Korea for 2 consecutive years but also been honored as the most respected hospital in Korea for 12 consecutive years by the Korea Management Consulting Association. Furthermore, in line with global development, ASAN has been listed among the top excellent hospitals in Korea and the Top 20 hospitals globally (according to the independent assessment from Newsweek magazine in 2019), while also receiving 4 Presidential Awards for National Health Promotion in 2014 and Best International Patient Care and Global Contribution in 2015.

In addition, ASAN possesses state-of-the-art equipment along with appropriate therapeutic methods and a team of professional, experienced physicians. It ensures absolute peace of mind for customers during the treatment process, especially for rare or complex cases.

• Blood cancer: The ASAN Cancer Institute is also at the forefront of breakthrough treatment methods.
• Lung cancer, liver cancer, and leukemia: It is the top facility in Korea for cure rates with 10 effective treatment methods (the 5-year success rate in treatment is almost double that of Singapore in these two types of cancer).
• Breast cancer: An impressive 97% survival rate, the highest globally for early-stage and maintained high rates for late-stage.
• Liver cancer: Excellent treatment results equivalent to the most prestigious hospitals worldwide. The Liver Cancer Center is recognized as the largest liver cancer treatment center in Korea.
• Moreover, in other types of cancer, the survival rates are also significantly higher than in developed countries. Historically, the hospital's bed-side risk rate is 0%, meaning it ensures the safety of both recipients and donors.

2. Osaka International Cancer Institute (OICI)

Osaka International Cancer Institute (OICI) leads the top three cancer centers in Japan for successful treatment rates of Colorectal, Stomach, and Lung cancers. It's also the sole institute equipped with state-of-the-art heavy ion therapy technology, offering optimal treatment solutions at the highest global standards. The Osaka International Cancer Institute (OICI) has been Japan's number one cancer institute in recent years, surpassing the National Cancer Center Japan in successful treatments for Colorectal and Stomach cancers for 10 consecutive years.

To continually enhance treatment quality, Osaka International Cancer Institute (OICI) pioneers in equipping modern medical equipment and selecting the most perfect and comprehensive treatments in Japan and even on a global scale. Starting from 2018, the Osaka International Cancer Institute (OICI) will officially introduce the latest generation of Carbon Heavy Ion therapy in Japan:

• This is an advanced and highly effective new cancer treatment method. Heavy ion therapy is an extremely precise form of radiation therapy that destroys tumors in the patient's body without causing many other side effects like conventional radiation therapy.
• The effectiveness of heavy ion therapy even brings about tumor destruction results 2-3 times better than the advanced Proton therapy, far surpassing conventional X-ray therapy at major cancer centers in Vietnam or Singapore.
• OICI is the only major cancer institute in Japan to offer heavy ion therapy solutions (meeting both criteria as a major multi-disciplinary cancer institute and owning carbon heavy ion therapy technology).

The National Cancer Centre Japan (NCCJ) was established by the Ministry of Health, Labour and Welfare of Japan in 1962, tasked with leading the nation's cancer treatment, prevention, control, research, and education programs. With a workforce of over 3,500 individuals, including 600 physicians and 1,200 nurses, the Centre provides comprehensive clinical services to patients across 2 hospitals with 1,000 beds. The 400 researchers at the institute conduct fundamental research.

The National Cancer Centre Japan also conducts research on prevention and screening, along with translational and clinical research, organizes national cancer registration and a national database on cancer genetics. Moreover, the number of clinical trials conducted ranks among the highest in Japan, and the National Cancer Centre Japan is recognized as the 'primary clinical research site' under Japan's Medical Care Act. Specifically, the Centre is currently strengthening research and clinical systems to address unmet medical needs, developing a framework based on genomic information to provide personalized treatment methods as well as systematic priority healthcare for each patient, and driving policy initiatives.

The National Cancer Centre Japan also provides accurate and up-to-date information to the public and healthcare professionals, while supporting 436 cancer organizations nationwide to ensure access to equitable care standards. The leadership participates in and leads specialized agencies designated by the Ministry of Health, Labour and Welfare in the fight against cancer. Expertise is shared with the global healthcare sector, focusing on the Asian region. The National Cancer Centre Japan actively collaborates with industry and academic research organizations as well as universities.

Tokyo University Hospital was established in Tokyo from as early as 1858, starting as the Kanda Otamagaike Vaccination Center. After more than 150 years, the hospital remains a driving force for both the medical field and healthcare in Japan, becoming Japan's number one hospital and a top 10 globally. Tokyo University Hospital operates with the mission of 'contributing to the development of clinical medicine and the advancement of healthcare professionals with the goal of providing the best healthcare services to patients.'

Tokyo University Hospital has a capacity of 1,210 beds (including 1,150 regular beds, 60 psychiatric beds) and 3,888 staff (comprising 2,554 full-time employees and 1,334 part-time employees). In just 2010, the hospital admitted 389,830 inpatients (an average of 1,074 patients/day) and 794,454 outpatients (an average of 3,079 patients/day) and performed 10,752 surgeries. Based on these annual figures, it can be affirmed that Tokyo University Hospital is one of the leading hospitals in Japan.

Tokyo University Hospital is also recognized as one of the top 10 largest and best hospitals in the world by Newsweek 2019. The hospital has successfully admitted and treated many international patients, but since 2013, with the assistance of the International Medical Center, the necessary functions to support foreign patients will be fully established, including translation support, medical record translation, and financial assistance to enable specialty departments to focus on their professional work.

National Cancer Centre Singapore (NCCS) is the nation's leading tertiary cancer center, handling 65% of all public cancer cases in Singapore. In addition to providing world-class cancer care services, the clinical physicians at the National Cancer Centre Singapore collaborate closely with scientists conducting robust translational and clinical research, advancing both domestically and internationally.

Clinical trials are the best way to improve cancer treatment outcomes, and National Cancer Centre Singapore (NCCS) is at the forefront of dynamic clinical trials to develop new and innovative treatment approaches for all types of cancer. With over two decades of experience, the Humphrey Oei Cancer Research Office has conducted over 450 phase I to III clinical trials to date and is currently monitoring over 200 ongoing trials at the National Cancer Centre Singapore.

Clinical trials at National Cancer Centre Singapore focus on evaluating the effectiveness of new molecular-targeted agents and next-generation immune therapy methods, while deploying the use of new technologies and digital medical tools. Biostatistical and epidemiological research is also conducted to assess real-time patient experiences. The National Cancer Centre Singapore has extensive collaborations in biotechnology and biopharmaceuticals for clinical and translational research, creating a system to bring effective treatment methods to the market and provide new hope for cancer patients.

6. Linkou Chang Gung Memorial Hospital

Linkou Chang Gung Memorial Hospital, also known as Chang Gung Memorial Hospital or simply 'Chang Gung Hospital,' is a hospital located in Guishan District, Taoyuan, Taiwan. Linkou Chang Gung Memorial Hospital is part of the Chang Gung Medical Foundation hospital network. It boasts nearly 4,000 beds, making it one of the largest bed-capacity hospitals. Chang Gung sees an average of 8.2 million outpatient visits annually, with 2.4 million inpatient treatments and an average of 167,460 surgical patients per year. Chang Gung has successfully completed over 1,000 liver transplants.

Approximately one-quarter of Taiwan's cancer patients are treated at Chang Gung Hospital healthcare facilities. Each year, Linkou Chang Gung Memorial Hospital, the largest cancer hospital, provides advanced multi-disciplinary treatment for over 8,000 newly diagnosed cancer patients, regardless of their background. The cancer center at Chang Gung Hospital is designed with the patient in mind. To provide the best treatment and care, the hospital is equipped with a full range of diagnostic and treatment equipment for cancer patients.

In the spacious outpatient clinic area of Chang Gung Hospital, flooded with natural light, patients can conveniently visit various oncology specialties in the same day. Medical record managers, nutritionists, psychiatrists, and volunteers are also available to provide comprehensive healthcare services. Patients are cared for and treated in a friendly, compassionate atmosphere, knowing they are not alone in this fight against cancer.

The cancer center building of Chang Gung Hospital houses oncology departments, bone marrow transplant units, and molecular diagnostic laboratories. There are also private rooms for outpatient chemotherapy, where non-admitted patients can receive infusion therapy comfortably and safely. To reduce the risk of infection due to decreased white blood cell counts after chemotherapy, there are isolation units for patients prone to infections. Additionally, the radiation oncology department is located in the basement to provide the most advanced radiation therapy methods.

To achieve the best possible treatment outcomes, Chang Gung Hospital has established specialized teams for various types of cancer. Within these teams are experts in medical oncology, surgical oncology, radiation oncology, medical imaging, and pathology. The teams aim to provide updated guidance to members to create the best treatment plans for patients. Each team is comprehensively evaluated to live up to the hospital's dedication, aiming for professionalism and excellence.

7. Samsung Medical Centre

When Samsung Medical Centre opened its doors in 1994, it revolutionized the domestic healthcare model with advanced concepts of customer satisfaction and patient-centric care. Over the past 20 years, Samsung Medical Centre has garnered much love and encouragement, securing the top position in the National Customer Satisfaction Index 14 times, and the top spot in the Korean Customer Satisfaction Index 16 times.

It has also held the top spot in the Korean Standard - Service Quality Index 12 times in a row, and Samsung Medical Centre has been selected as the top healthcare center in the hospital category in Brand Star for 12 consecutive years. The International Health Care Center (IHC) is a dedicated center for international patient care at Samsung Medical Centre (SMC), one of Korea's leading hospitals. IHC opened in September 1995 and is the premier medical clinic for resident foreigners and international patients in Korea.

To meet the needs and priorities of patients in delivering the best healthcare services, the hospital provides a range of in-clinic services including adult and pediatric healthcare, personal health checkups, and urgent care visits, while coordinating rapid referrals to over 800 experts in 40 departments of Samsung Medical Centre. Especially for cancer patients, the hospital consistently applies advanced techniques, proton therapy, state-of-the-art diagnostic equipment, and the latest cancer treatments.

8. Mount Elizabeth Hospital

Mount Elizabeth Hospital is a leading healthcare center in the Asia-Pacific region for over 30 years. The hospital has earned the trust of patients from around the world through a strategy that combines the convenience of private healthcare facilities, renowned for their breadth and depth of expertise, with quality nursing care and advanced modern technology.

Among private hospitals in Singapore, Mount Elizabeth is the largest and most renowned for the quality of medical care and services. As a part of Asia's largest healthcare group - Parkway Pantai, Mount Elizabeth boasts a large team of over 370 specialists and 1,161 highly qualified and compassionate doctors. Mount Elizabeth also ensures that all patients receive medical examination and treatment in the best environment with state-of-the-art equipment and modern advanced services combined with experienced healthcare professionals.

In a move to provide better access to a wide range of services for patients, Mount Elizabeth has expanded its operations in Singapore from one hospital in the city (Mount Elizabeth Orchard) to another new address in central Singapore (Mount Elizabeth Novena). Both hospitals are accredited by the prestigious Joint Commission International (JCI) for the quality of care and are the first private hospitals in Asia to receive the Asian Management Award for management and human development excellence. With its two hospital facilities, Mount Elizabeth ensures that patients can access world-class healthcare benefits through globally accredited medical facilities in the heart of Singapore.

National University Hospital Singapore (NUH) is a premier tertiary specialty hospital, providing advanced healthcare services with full clinical and subclinical specialties including Cardiology, Gastroenterology, Obstetrics, Cancer, Ophthalmology, Pediatrics, Orthopedic Trauma, Endoscopic Hand Surgery, and Reconstruction. Moreover, the hospital conducts organ transplant surgeries for adults such as (kidney, liver, and pancreas) and is the sole public hospital in Singapore performing kidney and liver transplants for pediatric patients.

With a team of proficient medical experts, National University Hospital Singapore offers the highest quality and most advanced medical care services. In 2007, NUH was chosen by the Singapore Ministry of Health to expand with two specialty centers: the National University Cancer Institute, Singapore (NCIS) and the National University Heart Centre, Singapore (NUHCS). The Cancer Institute provides all examination and treatment services for adult and pediatric cancer patients. The Heart Centre offers all programs for the examination and treatment of all heart-related diseases.

National University Hospital Singapore commenced operations on June 24, 1985, as Singapore's first restructured hospital. Annually, the hospital treats over a million patients. In 2004, NUH became the first hospital in Singapore to achieve international certification for good clinical practice and safety in healthcare from JCI. NUH continues to focus on providing excellent clinical quality and safety for patients through training doctors, nurses, clinical medical staff, and researching new medical treatment methods. It is a member of the National University Health System, which includes NUH and the Yong Loo Lin School of Medicine.

Cancer Center at Sheba Medical Center, headed by Dr. Raanan Berger, is Israel's leading cancer treatment center. Every year, the Cancer Center at Sheba Medical Center treats 4,500 new cancer patients and thousands of cancer patients come for treatment, undergoing various clinical monitoring procedures and tests.

The 360-degree approach to Cancer Treatment at Cancer Center at Sheba Medical Center reflects our professional, compassionate care for patients and their families through a fully integrated multidisciplinary treatment plan, including highest quality Medical Oncology-Cancer care services, patient-centeredness, as well as access to all support services such as psychological, palliative care, social services, etc. The Integrated Medical Center Tal provides a unique combination of complementary medical treatment methods with clinical scientific research.

The clinical treatment units of Cancer Center at Sheba Medical Center have nationally and internationally recognized physicians, each specializing in specific types of cancer treatment. The specialized units operate independently while collaborating with colleagues to create a comprehensive care treatment plan encompassing all necessary diagnoses and treatment methods for each patient, including personalized biologic therapy, immunotherapy, chemotherapy, surgery, and radiation therapy. The Radiation Therapy Institute is Israel's largest and most innovative radiation therapy center, with expertise, experience, and resources to perform advanced radiation treatment methods.

Radiation Therapy Institute at Cancer Center at Sheba Medical Center utilizes the newest and most sophisticated equipment and methods to deliver radiation for cancer treatment, including conformal therapy, IMRT, CT-guided radiation beam shaping, and unique breath control methods.